APA

Moulton R. D., Ruterbories K. J., Bedwell D. W. & Mohutsky M. A. (20151214). In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Moulton Richard D, Ruterbories Kenneth J, Bedwell David W and Mohutsky Michael A. 20151214. In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Moulton R. D., Ruterbories K. J., Bedwell D. W. and Mohutsky M. A. (20151214). In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Moulton Richard D, Ruterbories Kenneth J, Bedwell David W and Mohutsky Michael A. In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. : Drug metabolism and disposition: the biological fate of chemicals. 20151214.